Efficacy and Safety of Tumor Necrosis Factor Antagonists in Treatment of Internal Fistulizing Crohn's Disease-Reference-Cited by-同舟云学术

Efficacy and Safety of Tumor Necrosis Factor Antagonists in Treatment of Internal Fistulizing Crohn's Disease

Published:2020-03 Issue:3 Volume:18 Page:628-636
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Bouguen Guillaume,Huguet Audrey,Amiot Aurélien,Viennot Stéphanie,Cholet Franck,Nachury Maria,Flamant Mathurin,Reimund Jean-Marie,Desfourneaux Véronique,Boureille Arnaud,Siproudhis Laurent

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference29 articles.

1. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology;Silverberg;Can J Gastroenterol,2005

2. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort;Thia;Gastroenterology,2010

3. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications;Satsangi;Gut,2006

4. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease;Louis;Gut,2001

5. Strategies for the care of adults hospitalized for active ulcerative colitis;Pola;Clin Gastroenterol Hepatol,2012

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential for medical therapies to address fistulizing Crohn’s disease: a state-of-the-art review;Expert Opinion on Biological Therapy;2024-07-24

2. Is infliximab therapy currently relevant in patients with inflammatory bowel diseases? (review);Koloproktologia;2024-06-21

3. Long-term outcomes of intestinal penetrating Crohn’s disease following successful nonoperative management;European Journal of Gastroenterology & Hepatology;2024-04-05

4. Prognostic factors for the efficacy of infliximab in patients with luminal fistulizing Crohn’s disease;BMC Gastroenterology;2023-03-08

5. Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCU;American Journal of Gastroenterology;2023-01-25